Bought a first position today of this cashed up company. After the recent offerings the cash is at the same level as the current market cap of $18 million. Quarterly burn rate is $1.6 million. SenesTech, Inc. (SNES) CEO Ken Siegel on Q4 2020 Results - Earnings Call Transcript Mar. 25, 2021 https://seekingalpha.com/article/44...l-on-q4-2020-results-earnings-call-transcript “Frankly, I hope the sense that you got from the call is, is we're up, we're upbeat, we're optimistic about the year the various things that we've taken close to a year and a half to put in place are finally clicking. And you know, we've got an energized sales team, we've got an energized marketing function and we have cash in the bank, so that we're not constantly worrying about that thing. So again, hopefully you'll be hearing good things from us over the next several quarters. Look forward to talking to you again at the end of Q1. Thanks all.” About SenesTech SenesTech is changing the model for pest management by targeting one of the root causes of the problem: reproduction. ContraPest® is an innovative technology with an approach that targets the reproductive capabilities of both sexes in rat populations, inducing egg loss in female rats and impairing sperm development in males. Using a proprietary bait delivery method, ContraPest® is dispensed in a highly palatable liquid formulation that promotes sustained consumption by rat communities. ContraPest® is designed, formulated and dispensed to be low hazard for handlers and non-target species such as wildlife, livestock and pets, where the active ingredients break down rapidly. We believe ContraPest® will establish a new paradigm in rodent control, resulting in a decreased reliance on lethal options. For more information visit the SenesTech website at www.senestech.com.